Nhan L Tran

Author PubWeight™ 42.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cell migration and invasion assays. Methods 2005 2.32
2 N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Res 2006 1.71
3 Role of synaptojanin 2 in glioma cell migration and invasion. Cancer Res 2004 1.64
4 The tyrosine kinase pyk2 promotes migration and invasion of glioma cells. Neoplasia 2005 1.60
5 The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol 2008 1.57
6 MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int J Cancer 2011 1.55
7 Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 2003 1.52
8 Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression. Nat Cell Biol 2010 1.47
9 EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Am J Pathol 2005 1.41
10 The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity. Mol Cancer Res 2008 1.23
11 Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma. Int J Cancer 2007 1.15
12 Regulation of glioma cell migration by serine-phosphorylated P311. Neoplasia 2005 1.11
13 Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation. Mol Cancer Res 2003 1.10
14 Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells. Mol Cancer Res 2012 1.08
15 Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function. Mol Cancer Res 2009 1.08
16 The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatment. J Invest Dermatol 2012 1.07
17 TWEAK and Fn14: new molecular targets for cancer therapy? Cancer Lett 2006 1.06
18 Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression. Front Oncol 2013 1.05
19 Molecular pathways triggering glioma cell invasion. Expert Rev Mol Diagn 2006 1.03
20 TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling. Mol Cancer Res 2010 1.03
21 The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression. Mol Cancer Res 2013 0.99
22 Critical role of the FERM domain in Pyk2 stimulated glioma cell migration. Biochem Biophys Res Commun 2006 0.98
23 IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors. Cancer Lett 2013 0.98
24 The Pyk2 FERM domain as a target to inhibit glioma migration. Mol Cancer Ther 2009 0.98
25 The small GTPase RhoG mediates glioblastoma cell invasion. Mol Cancer 2012 0.98
26 Role of TWEAK and Fn14 in tumor biology. Front Biosci 2007 0.96
27 Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion. Am J Pathol 2012 0.96
28 Reciprocal activation of transcription factors underlies the dichotomy between proliferation and invasion of glioma cells. PLoS One 2013 0.93
29 Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts. J Neurooncol 2008 0.90
30 miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2. PLoS One 2012 0.89
31 The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2. J Biol Chem 2013 0.88
32 TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance. Mol Cancer Res 2013 0.84
33 Identification of a functional peroxisome proliferator activated receptor response element in the 3' untranslated region of the human bcl-2 gene. Int J Oncol 2004 0.81
34 FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion. Clin Exp Metastasis 2014 0.81
35 Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response. Mol Cancer Res 2014 0.80
36 Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis. J Biol Chem 2013 0.79
37 A Novel Interaction between Pyk2 and MAP4K4 Is Integrated with Glioma Cell Migration. J Signal Transduct 2013 0.78
38 Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioblastoma cell chemotaxis via Lyn activation. Carcinogenesis 2013 0.78
39 An integrated approach to identifying clinically relevant targets in pediatric gliomas. CNS Oncol 2013 0.75